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1875-9572/Copyrightª 2016, Taiwan P
NC-ND license (http://creativecommoBackground: Bronchopulmonary dysplasia (BPD) remains the most common complication of
very low birth weight (VLBW) preterm infants, and inflammatory regulation plays a role in
the development of the BPD. Interleukin-6 (IL-6) has an important role in airway inflammation
and therefore can be used as a marker of airway injury. The study aimed to compare the
changes between IL-6 and oxidative stress marker with 8-hydroxy-20-deoxyguanosine (8-
OHdG) from serum and tracheal aspiration (TA) in VLBW preterm infants following develop-
ment of BPD.
Methods: This birth cohort study enrolled 80 VLBW preterm infants, including 26 who devel-
oped BPD. All infants completed the study and survived at 36 weeks postmenstrual age. IL-6
and 8-OHdG concentrations from serum and TA on Day 1 and Day 28 after birth were measured
using immunoassay.
Results: IL-6 and 8-OHdG in serum and TA were higher in the BPD group than in the non-BPD
group on the 1st day after birth (p < 0.05). The IL-6 and 8-OHdG levels in TA fluid were persis-
tently increased on the 28th day of life in the BPD group (p < 0.05). The TA IL-6 was positivelyof Pediatric, Changhua Christian Children Hospital, Number 135, Nanshiao Street, Changhua City 500,
(Y.-G. Tsai).
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http://dx.doi.org/10.1016/j.pedneocorrelated with 8-OHdG levels on the 1st day (rZ 0.64, p < 0.05) and 28th day of life (rZ 0.76,
p < 0.05). Based on receiver operating characteristic curves as a predictor of BPD develop-
ment, TA IL-6 (cutoff, 456.8 pg/mg) had 81.5% sensitivity and 77.8% specificity, whereas TA
8-OHdG (cutoff, 4.4 ng/mg) had a sensitivity of 81.5% and a specificity of 64.4%.
Conclusion: Persistent inflammation with oxidative DNA damage in the respiratory tract may
be a crucial mechanism in BPD.
Copyright ª 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
As neonatal intensive care has improved in the past
40 years, the survival rate of premature infants has also
significantly increased.1 Bronchopulmonary dysplasia (BPD)
remains the most common complication of very low birth
weight (VLBW) preterm infants, causing long-term pulmo-
nary complications and large financial burdens on the so-
ciety and families.2 BPD is a chronic lung condition and the
pathogenesis of BPD had been linked to immature lung
tissue, barotrauma resulting from mechanical ventilation,
oxidant injury, and proinflammatory mediators with
inflammation, enlarged airspaces, thick septal walls, and
abnormal development of alveolar capillaries.3,4
Oxidative stress clearly occurs early in pregnancy and
continues in the postnatal period. Preterm infants have
decreased antioxidant defenses in response to oxidative
challenges because they exhibit accelerated production of
free radicals and limited antioxidant protection.5 Thus,
premature infants are more sensitive to oxidative stress
damage in the lung, especially when supplemental oxygen
or ventilator support is delivered for long periods.6e8
Several studies demonstrated that elevated levels of
several inflammatory cytokines and chemokines in the
serum and lungs cytokines of preterm neonates during the
1st week of life were associated with the development of
BPD.9e11 Fetal inflammatory response syndrome (FIRS) was
originally defined as an elevation of the fetal plasma
interleukin-6 (IL-6) concentration, and it was characterized
by systemic activation of the fetal immune system with risk
factors for BPD.12,13 IL-6 was the major proinflammatory
cytokine mediating acute lung injury and exacerbating
ventilator-induced lung injury.14e16 High IL-6 cytokine
concentrations in tracheal aspirates and umbilical cord
plasma of extremely low birth weight infants are consid-
ered to be an independent risk factor for BPD.17e19
Oxidative stress causes DNA, lipid, and protein damage.
Guanine is the DNA base most prone to oxidation, both in
the nucleus and in mitochondria. Upon oxidation, a hy-
droxyl group is added to the C-8 position of the guanine
molecule, resulting in 8-hydroxy-20-deoxyguanosine (8-
OHdG), one of the most common forms of free radical-
induced lesions of DNA.20 Recently, 8-OHdG has been used
widely as a biomarker for the measurement of endogenous
oxidative DNA damage.8,20,21
Oxidative stress and proinflammatory processes are
strongly related, and oxidative stress may have a worse
effect on inflammation of premature lungs.22 So far, only aHsiao C-C, et al., Correlates of E
irth Weight Infants Who Develop
.2016.01.004few studies have been conducted on inflammatory cyto-
kines and oxidative marker from tracheal aspirates in BPD
development among VLBW neonates. This study assessed
the relationship between 8-OHdG and IL-6 levels from
serum and tracheal aspiration (TA) and development of BPD
among VLBW infants. These findings may provide further
evidence to promote specific therapeutic approaches to
BPD.2. Material and methods2.1. Patient populations
We enrolled 80 VLBW infants with gestational age (GA) of <
32 weeks and weighing < 1250 g, who were maintained on
mechanical ventilation for respiratory failure in the
neonatal intensive care unit (NICU) of Changhua Christian
Children’s Hospital, Changhua City, Taiwan. The infants
were initially managed on conventional mechanical venti-
lators. High-frequency oscillatory ventilation was used as a
rescue mode for infants not responding to conventional
ventilation or those requiring high peak inspiratory pres-
sures (> 20 cmH2O). Relevant clinical datadsuch as birth
weight (BW), GA, sex, cesarean delivery, Apgar score,
prenatal and postnatal steroids, respiratory distress syn-
drome (RDS), surfactant therapy, requirement of supple-
mental oxygen, ventilator days, presence of sepsis,
retinopathy of prematurity, patent ductus arteriosus,
necrotizing enterocolitis (NEC), and intraventricular hem-
orrhagedwere collected from the patients’ chart records.
BPD was defined as oxygen dependency at 28 postnatal days
and at postmenstrual age of 36 weeks.7 The primary
outcome is comparing the relationship between 8-OHdG
and IL-6 levels form serum and TA and development of
BPD among VLBW infants. The secondary outcome is using
receiver operating characteristic (ROC) curve analysis to
select a cutoff value to predict BPD.
Infants were excluded from the study if they had any of
the following: (1) chromosomal disorders or lethal
congenital abnormalities; (2) congenital cyanotic heart
disease; (3) anatomic obstructive gastrointestinal pathol-
ogies, such as intestinal malrotation with or without
volvulus, stenosis, or atresia, gastroschisis, omphalocele,
and Hirschsprung’s disease; or (4) confirmed or family his-
tory of hereditary metabolic disorder. The same attending
physician took care of the infants during their hospital stay
but was blinded to their IL-6 and 8-OHdG values. Thelevated Interleukin-6 and 8-Hydroxy-20-Deoxyguanosine Levels in
Bronchopulmonary Dysplasia, Pediatrics and Neonatology (2016),




BPD (n Z 26)
Male sex 32 (50) 14 (54)
Gestational age, wk 28.5 (24e32) 26.5 (24e32)y
Birth weight, g 1080.5 (654
e1460)
816 (491e1206)y
Cesarean delivery 39 (72.2) 18 (69.2)
Antenatal steroid 32 (59.3) 14 (53.8)
Respiratory distress
syndrome
27 (50) 21 (80.7)y
Surfactant use 9 (16.7) 11 (42.3)y
1-min Apgar score 6 (1e8) 5 (0e7)y
5-min Apgar score 8 (5e9) 7 (3e9)y
Day 1 blood WBC (103/mL) 15.0 (3.5
e27.2)
19.3 (4.3e25.5)
Day 1 blood CRP (mg/dL) 0.14 (0.02
e3.98)
0.52 (0.02e16.61)y
Ventilator days 3 (0e60) 30 (0e75)y
O2 days 40.5 (0e85) 82 (10e120)
y
ROP grades 0 (0e3) 2 (0e3)y
NEC 0 1 (3.8)
PDA 26 (48.1) 18 (69.2)
Sepsis 3 (5.6) 6 (23.1)y
Intraventricular
hemorrhage grades
0 (0e2) 0 (0e4)y
Data are presented as n (%) or median (range).
BPDZ bronchopulmonary dysplasia; CRPZ C-reactive protein;
NEC Z necrotizing enterocolitis; PDA Z patent ductus arte-
riosus; ROP Z retinopathy of prematurity; WBC Z white blood
cell count.
* Differences between the two groups were assessed by
Fisher’s exact test for categorical data and ManneWhitney U
test for continuous variables.
y p < 0.05.
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following established protocols. The attending physicians
decided by consensus while management protocols, clinical
practices, equipment, and key personnel in the NICU were
maintained throughout the study period. The study was
approved by the Institutional Review Board at Changhua
Christian Children’s Hospital, and informed consent was
obtained from the parents.
2.2. TA and neonatal serum collection
The TA samples were collected using a well-established
technique in accordance with American Thoracic Society
guidelines.23 Tracheal suctioning in intubated infants was
performed by the nurse and respiratory therapist to main-
tain airway patency as necessary. TA in infants weaned
from ventilator at Day 28 was performed by the physician
using direct laryngoscopy and passage of 8F suction cath-
eter into the trachea to avoid oropharyngeal contamina-
tion. The samples were immediately transported on ice,
processed within 30 minutes in the laboratory, and centri-
fuged at 4C for 10 minutes at 300g. The supernatant was
collected, divided into aliquots, and stored at 80C for
future use. Neonatal serum was drawn directly from the
neonatal vein on Day 1 and Day 28 after birth.
2.3. Enzyme-linked immunosorbent assay
Total protein concentration was measured in each TA
sample using the Bradford assay (Bio-Rad, Richmond, CA,
USA) to correct for dilution during the lavage procedure.24
The levels of IL-6 in the serum and TA fluid were measured
using commercially available enzyme-linked immunosor-
bent assay (ELISA; R&D Systems, Minneapolis, MN, USA)
according to the manufacturer’s instructions. The oxidative
stress marker formation of 8-OHdG by oxygen radicals was
measured using a highly sensitive 8-OHdG ELISA kit (JalCA,
Fukuroi, Shizuoka, Japan). The levels of 8-OHdG and IL-6
were expressed as ng/mg and pg/mg of protein,
respectively.
2.4. Statistical analysis
To assess whether clinical background variables differed
between preterm infants with and without BPD, Fisher’s
exact tests were used for categorical data, and Man-
neWhitney U test was used for continuous data. Within-
group comparison of changes from baseline was carried
out by means of the two-sided Wilcoxon signed rank test.
Data are expressed as median (range). The ROC curve
analysis was used to select cutoff value to predict BPD. All
tests were two-sided with a 5% significance level.
3. Results
Eighty preterm neonates were enrolled, including 48 who
developed RDS and 26 who developed BPD at the post-
menstrual age of 36 weeks. Based on their demographic
characteristics (Table 1), the neonates who developed BPD
were lighter (p < 0.05) and more immature (p < 0.05),Please cite this article in press as: Hsiao C-C, et al., Correlates of E
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http://dx.doi.org/10.1016/j.pedneo.2016.01.004whereas more of those with RDS required surfactant
treatment (p < 0.05) (Table 1). Neonates’ 1- and 5-minute
Apgar scores were lower in the BPD group (p < 0.05). The C-
reactive protein concentrations in serum within 24 hours
after birth were higher (p < 0.05) in the BPD group than in
the non-BPD group (Table 1).
The duration of mechanical ventilation and oxygen
therapy were significantly longer in the BPD group. The
frequencies of retinopathy of prematurity, intraventricular
hemorrhage, and sepsis were lower in the non-BPD group as
shown in Table 1.
The oxidative stress marker with 8-OHdG from serum
were higher in the BPD group than in the non-BPD group on
Day 1 [19.6 (9.8e176.8) ng/mL vs. 18.8 (5.9e50.6) ng/mL,
p < 0.05] and Day 28 [39.5 (11.3e115.4) ng/mL vs. 17.3
(3.8e51.6) ng/mL, p < 0.05] after birth. Serum 8-OHdG was
significantly higher on Day 28 than on Day 1 in the BPD
group (p < 0.05; Figure 1A). Serum IL-6 was significantly
higher in the BPD group than in the non-BPD group on Day 1
of life (p < 0.05; Figure 1B). In tracheal aspirate fluid (TA),
8-OHdG was significantly higher in the BPD group on Day 1
[9.5 (1.8e42.9) ng/mg vs. 3.7 (0.3e16.1) ng/mg, p < 0.05]
and Day 28 [23.3 (6.3e95.8) ng/mg vs. 2.6 (0.3e11.4) ng/
mg, p < 0.05] of life. Under the same condition, TA IL-6 waslevated Interleukin-6 and 8-Hydroxy-20-Deoxyguanosine Levels in
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Figure 1 Level of 8-OHdG and IL-6 in serum from VLBW in-
fants who developed BPD. (A) Serum 8-OHdG and (B) IL-6 on
postnatal Day 1 and Day 28 according to the absence or pres-
ence of BPD. The box plots show the 25th percentile and 75th
percentile. * p < 0.05 between BPD and non-BPD groups.
y p < 0.05 between Day 1 and Day 28. BPDZ bronchopulmonary
dysplasia; IL-6 Z interleukin-6; 8-OHdG Z 8-hydroxy-20-deox-
yguanosine; VLBW Z very low birth weight.
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Figure 2 Level of 8-OHdG and IL-6 in tracheal aspirates from
VLBW infants who developed BPD. (A) 8-OHdG and (B) IL-6 from
tracheal aspirates on postnatal Day 1 and Day 28, according to
the absence or presence of BPD. The box plots show the 25th
percentile and 75th percentile. * p < 0.05 between the BPD and
non-BPD groups. y p < 0.05 between Day 1 and Day 28.
BPD Z bronchopulmonary dysplasia; IL-6 Z interleukin-6; 8-
OHdG Z 8-hydroxy-20-deoxyguanosine; VLBW Z very low
birth weight.
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(155.0e1660.6) pg/mg vs. 276.3 (25.1e1182.0) pg/mg,
p < 0.05] and Day 28 [962.5 (142.5e3037.5) pg/mg vs. 237.5
(0.5e806.3) pg/mg, p < 0.05] of life. Both IL-6 and 8-OHdG
in TA fluid were persistently higher on postnatal Day 28 than
Day 1 in the BPD group (p < 0.05; Figures 2A and 2B). In
contrast, IL-6 and 8-OHdG were decreased in TA fluid on
Day 28 than Day 1 of life in the non-BPD group (p < 0.05;
Figures 2A and 2B).
Serum IL-6 levels were positively correlated with 8-
OHdG levels on postnatal Day 28 (r Z 0.62, p < 0.05;
Figure 3B). TA IL-6 was positively correlated with 8-OHdG
levels on postnatal Day 1 (r Z 0.64, p < 0.05) and Day 28
(r Z 0.76, p < 0.05; Figures 3C and 3D). Based on ROC
curves, TA IL-6 on Day 1 (cutoff, 456.8 pg/mg) had 81.5%
sensitivity, 77.8% specificity, and 0.85 area under the curve
(AUC), indicating a good predictive effect on BPD
(Figure 4A). Applying this FIRS blood IL-6 cutoff value ofPlease cite this article in press as: Hsiao C-C, et al., Correlates of E
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http://dx.doi.org/10.1016/j.pedneo.2016.01.00411 pg/mL to predictive BPD, blood IL-6 on Day 1 had a
sensitivity, specificity, and area under curve of only 0.52,
0.56, and 0.571, respectively (data not shown). Based on
ROC curves to examine 8-OHdG levels to predictive effect
on BPD, TA 8-OHdG levels on Day 1 (cutoff, 4.4 ng/mg)
showed a sensitivity of 81.5%, a specificity of 64.4%, and an
area under curve of 0.77 (Figure 4B). However, using serum
8-OHdG level of 4.6 ng/mL to predictive BPD had a sensi-
tivity of 61.5%, a specificity of 69.6%, and an area under
curve of 0.698. In addition, we examined the correlations
between birth body weight (BBW) and IL-6 and 8-OHdG
levels on Day 1. We found that BBW showed a small nega-
tive correlation with serum 8-OHdG levels (r Z 0.27,
P < 0.05) on the 1st day of life. We further examined
whether GA and BBW confounded the correlation between
IL-6 and 8-OHdG levels using a multiple regression model,
and the results showed that GA or BBW did not decrease thelevated Interleukin-6 and 8-Hydroxy-20-Deoxyguanosine Levels in
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Figure 3 Correlation between serum and tracheal aspirates levels of IL-6 and 8-OHdG levels on (A and C) postnasal Day 1 and (B
and D) Day 28 of life. IL-6 Z interleukin-6; 8-OHdG Z 8-hydroxy-20-deoxyguanosine.
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(data not shown).4. Discussion
The present study demonstrated that IL-6 and 8-OHdG from
serum and TA were higher in the BPD group than in the non-
BPD group on the 1st day after birth. The IL-6 and 8-OHdG
levels in TA fluid were also persistently increased on post-
natal Day 28 in the BPD group. The TA IL-6 was positively
correlated with 8-OHdG levels on postnatal Day 1 and Day
28. These results suggest that persistent inflammation with
oxidative distress and DNA damage in the respiratory tract
can be an important mechanism in the pathogenesis of BPD.
BPD, periventricular leukomalacia, NEC, and retinopathy
of prematurity are associated with oxidative stress, which
can be defined as an imbalance between reactive oxygen
species (ROS) production and antioxidant defenses.6,25,26
Oxygen toxicity leads to increased production of oxygen
free radicals that may contribute to lung inflammation and
airway remodeling in chronic lung disease.27 Increased
levels of markers of DNA oxidation indicate that neonates
receiving high oxygen levels generate more ROS, which is
correlated with the later development of BPD.27e29 Our
finding revealed that infants who developed BPD had
significantly longer duration of ventilation therapy and
higher total oxygen requirements with persistentlyPlease cite this article in press as: Hsiao C-C, et al., Correlates of E
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http://dx.doi.org/10.1016/j.pedneo.2016.01.004elevated 8-OHdG levels in serum and TA fluid (Figures 1A
and 2A). This confirms previous findings indicating that
high oxygen exposure increased oxidative stress. Joung
et al8 demonstrated that high urinary 8-OHdG levels could
predict BPD. Although urinary sampling with 8-OHdG levels
is noninvasive, TA 8-OHdG may be suitable for direct eval-
uation of airway oxidative stress. In this study, we found
that TA 8-OHdG (AUC Z 0.77) more accurately predicted
BPD than serum 8-OHdG (AUCZ 0.698) level by ROC curve.
BPD is thought to develop and progress because of
imbalanced pro- and anti-inflammatory mechanisms.12e14
Gomez et al30 identified 11 pg/mL as the cutoff value for
cord blood IL-6 for defining the presence of FIRS and
identifying infants at risk for severe neonatal morbidity
with RDS, neonatal sepsis, pneumonia, intraventricular
hemorrhage, NEC, and BPD. The presence of FIRS is a risk
factor for BPD, with a longer duration of mechanical
ventilation and oxygen support.13 In the current analysis,
preterm infants who developed BPD had significantly higher
blood IL-6 concentrations compared with infants who did
not develop BPD (Figure 1B). The study provides further
evidence to support a link between raised inflammatory
marker C-reactive protein and serum IL-6 and adverse
neonatal outcome with sepsis, intraventricular hemor-
rhage, and retinopathy of prematurity (Table 1) in BPD
group, highlighting the importance of targeting prevention
and treatment of antenatal inflammation in order to pre-
vent neonatal morbidity.levated Interleukin-6 and 8-Hydroxy-20-Deoxyguanosine Levels in
Bronchopulmonary Dysplasia, Pediatrics and Neonatology (2016),
Figure 4 Cutoff value of tracheal aspirates (A) IL-6 and (B) 8-
OHdG concentration within 24 hours after birth for predicting
BPD by receiver operating characteristic curve. IL-
6 Z interleukin-6; 8-OHdG Z 8-hydroxy-20-deoxyguanosine.
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+ MODELProinflammatory cytokines directly induce acute lung
injury and exacerbate ventilation-associated lung injury,
thus promoting pulmonary remodeling and development of
chronic lung disease.31,32 Several authors have stated that
infants with respiratory distress who subsequently devel-
oped BPD had high IL-6 level in tracheal aspirate.10,22,33 In
our study population, there was an impressively consistent
cutoff value of 456.8 pg/mg from IL-6 TA using the ROC
curve analysis for predicting BPD (81.5% sensitivity, 77.8%
specificity, and 0.85 area under curve). In addition, we
found persistently increased IL-6 TA levels on the 28th day
of life in the BPD group.Please cite this article in press as: Hsiao C-C, et al., Correlates of E
Tracheal Aspirates from Very Low Birth Weight Infants Who Develop
http://dx.doi.org/10.1016/j.pedneo.2016.01.004The present study established a persistently positive
correlation between IL-6 and 8-OHdG from TA in the BPD
group. This may be attributable to high oxygen and lung-
stretching, both of which lead to increased ROS production
and the activation proinflammatory cytokines.34 However,
some conflicting lines of evidence showed the functional
role of IL-6 in the development of BPD during hyperoxia
exposure. IL-6 demonstrated the cytoprotective effects
against oxygen injury in adult mature mice model.35 By
contrast, IL-6 could cause mortality, DNA injury, and
apoptosis, and enhance the expression of angiogenic fac-
tors in hyperoxia in neonatal mice.36 Increased IL-6 in
bronchoalveolar lavage by sequential analysis during
hyperoxia exposure was noted in neonatal rats.37 Taken
together, these observations suggest that the development
of BPD may be multifactorial and warrant further explora-
tion to evaluate the action of IL-6 in hyperoxic lung injury.
Multiple clinical trials have attempted to decrease the
use of supplemental oxygen therapy to reduce the inci-
dence of BPD.38 At present, no therapeutic strategy has
been validated as prevention or treatment against BPD.
Tocilizumab, an anti-IL-6 receptor antibody, is effective in
the treatment of various autoimmune and inflammatory
conditions notably in juvenile rheumatoid arthritis.39 It is
the only IL-6 pathway targeting agent approved by regula-
tory agencies for clinical use and may be a new approach to
BPD prevention in high-risk preterm infants. However, more
experimental and preliminary human studies are needed to
prove its benefit before it can be used in preterm infants in
the near future.
In conclusion, the present study demonstrates that high
oxidative stressand increased IL-6 fromTAareassociatedwith
a higher incidence of BPD. Favorable regulation of the oxida-
tive stress and improved balance of pro- and anti-
inflammatory mechanisms may lead to the development of a
new therapeutic strategy to prevent the development of BPD.
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